CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...
Phase 3
Taipei, Taiwan and 45 other locations
study is to measure the safety and efficacy of insulin efsitora alfa (LY3209590) compared with insulin degludec in participants with type 1 diabetes...
Phase 3
Taipei City, Taipei, Taiwan and 76 other locations
To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...
Taipei City, Taiwan and 89 other locations
with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (<16 cm2 vs ≥16 cm2 ) will ...
Phase 3
Taipei, Taiwan and 20 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Taipei, Taiwan and 636 other locations
This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...
Phase 3
Taipei, Taiwan and 87 other locations
in people with peripheral arterial disease (PAD) and type 2 diabetes. Participants will either get semaglutide or placebo ("dummy") medicine...
Phase 3
Taipei, Taiwan and 124 other locations
The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Part...
Phase 3
Taoyuan city, Taiwan and 467 other locations
in improving blood sugar control in participants with type 2 diabetes (T2D) with inadequate glycemic control using metformin. The study will...
Phase 3
Taipei, Taiwan and 77 other locations
The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...
Phase 3
Taipei City, Taipei, Taiwan and 93 other locations
Clinical trials
Research sites
Resources
Legal